The participants will be able to review and discuss research regarding non-hepatic malignancy in the candidate, the donor or the recipient, including selection criteria/indications, prognostic models, surveillance strategies, novel therapies and management.
The participants will gain insight into innovations that lead to improvement in the field of liver transplantation in candidates or donors with a history of malignancy, and in recipients with de novo cancer, both in adult and pediatric populations.